Eric Levin is the co-founder and CEO of Scripta Insights, a Needham, Massachusetts healthcare technology company that helps self-insured employers and health plans cut prescription drug costs by flagging clinically equivalent, lower-cost medication alternatives. A serial entrepreneur who has managed products with more than $5 billion in cumulative sales and been part of 32-plus mergers and acquisitions, Levin previously helped grow The Learning Company alongside Kevin O'Leary into a business that sold for $3.6 billion. Since taking the CEO seat at Scripta in 2017, he has positioned the company as an unbiased transparency layer over the opaque pharmacy benefits industry, growing it to 80-plus clients and $42 million in total funding.
Garrett Fienberg is the Chief Executive Officer of Truveris, a pharmacy cost containment company that has built an independent, data-led technology platform to bring transparency to PBM pricing and drive down drug costs for employers and benefit consultants. He joined Truveris in 2021, was elevated to Chief Operating Officer in March 2024, and stepped into the CEO role in 2025. Over a 20-plus-year career he has founded and sold venture-backed startups, run growth for a publicly traded healthcare SaaS company, and worked across venture capital, hedge funds, investment banking, and consulting.
Catalina Gorla is the co-founder and CEO of TruDataRx, a Vermont-based health technology company that helps self-insured employers cut pharmacy spend using objective clinical data and comparative-effectiveness analytics. A Dartmouth-educated former economist turned healthcare entrepreneur, she has spent over a decade attacking the hidden costs and conflicts of interest baked into American drug pricing. She previously co-founded Informulary, managed innovation programs at the Dartmouth Center for Healthcare Delivery Science, and delivered a TEDxBeaconStreet talk arguing the U.S. doesn't need a single payer so much as an informed one.